|  1 |  | Primary 155 Jefferson Dr  | Menlo Park  |  US |  | Gala Therapeutics  | N/A  | James Stambaugh  | Senior Vice President, Clinical Affairs & Strategy at Gala Therapeutics  | 
|  2 |  | Primary One Kendall Square  | Cambridge  |  US |  | Artificial Cells As Novel Therapeutics  | N/A  | Felix Moser  | Biological Engineer based in Boston, MA and Vancouver, BC  | 
|  3 |  | Primary London  | London  |  GB |  | Digital Therapeutics For Digestive Health  | N/A  | elena mustatea  | Chief Executive Officer  | 
|  4 |  | Primary Im Neuenheimer Feld 515  | Heidelberg  |  DE |  | Transforming Ocular Therapeutics  | N/A  | daniela willen  | director, clinical development ophthalmology  | 
|  5 |  | Primary 383 S Colorow Dr  | Salt Lake City  |  US |  | Discovering and Developing D-Peptide Therapeutics  | N/A  | Neil Berkley  | Vice President, Head of Business Development at Halozyme Therapeutics, Inc.  | 
|  6 |  | Primary  | San Diego  |  US |  | A Next Generation Therapeutics Company  | N/A  | Brian Cajes  | Head of Data and Engineering at Empirico Inc.  | 
|  7 |  | Primary 45 Caprice Ct.   | Jupiter  |  US |  | Transforming Therapeutics  | N/A  | Striechman Ron  | Member Of The Board Of Advisors at Beacon-Accelerator  | 
|  8 |  | Primary 601 Genome Way Suite 2100  | Huntsville  |  US |  | Linking Diagnostics To Therapeutics™  | N/A  | Kym Julius Creekmore, CHC  | N/A  | 
|  9 |  | Primary Chesterford Research Park  | Little Chesterford  |  GB |  | Excellence In Single Domain Therapeutics  | N/A  | David Burns  | Cofounder & Director at D&R Strategic Solutions Ltd.  | 
|  10 |  | Primary 11100 Endeavor Court  | Manassas  |  US |  | Microbiome Therapeutics  | N/A  | Anneke Seley  | Next Generation Sales Expert and Advisor, Author, Early Oracle Digital Sales Leader, Founder of Oracle Inside Sales  | 
|  11 |  | Primary 3401 Market St  | Philadelphia  |  US |  | Discovering Novel Antiviral Therapeutics  | N/A  | Michael Saporito  | Biopharmaceutical Consultant  | 
|  12 |  | Primary 200 Crescent Court Suite 455  | Dallas  |  US |  | Hedge Fund Focused On Biotech/Pharma/Therapeutics  | N/A  | Neil Shahrestani, MD  | Portfolio Manager - Biotech/Therapeutics  | 
|  13 |  | Primary 300 Brookside Ave  | Lower Gwynedd Township  |  US |  | A Gyroscope Therapeutics Company  | N/A  | Rose McKinley  | Vice President, Human Resources & Organizational Development  | 
|  14 |  | Primary 1 Broadway Fl 14  | Cambridge  |  US |  | An Immune-Driven Global Bio-Therapeutics Company  | N/A  | musheng bao  | Director  | 
|  15 |  | Sinbuk-ro, Sinbuk-eup 61-20  | Gagnam-gu  |  KR |  | From Aesthetics To Therapeutics  | N/A  | Monica Kyong Ye Cho  | HUGEL Head Of Legal/Compliance  | 
|  16 |  | Primary 11 Scorsbey Road  | Bayswater  |  AU |  | Delivering Quality Therapeutics  | N/A  | Timothee Murcier  | Area Manager Asia and Middle East at Fairmont Medical Products Pty Ltd  | 
|  17 |  | Primary London Bioscience Innovation Centre, 2 Royal College Street  | LONDON  |  GB |  | Innovative Ocular and Cancer Therapeutics  | N/A  | Salman Rahman  | Commercial Lead at University of Hertfordshire--------President and Co-founder of VASGEN LIMITED  | 
|  18 |  | Primary 25350 Magic Mountain Pkwy Suite #300  | Santa Clarita  |  US |  | Digital Therapeutics For Hearing  | N/A  | Daehee Lee  | GoldenEar Company, Inc. CEO  | 
|  19 |  | Primary Mesogeiwn 2- 4 Athens Tower  | Athens  |  GR |  | Health & Fertility Therapeutics  | N/A  | Harroula Mathiopoulou Bilali  | Molecular Biologist| Health Futurist| Genomics, Biotech, Pharma  | 
|  20 |  | Primary 19 Morris Ave. Building 128  | Brooklyn  |  US |  | People-Driven Therapeutics  | N/A  | Stephane Castel  | Co-Founder at Variant Bio  |